Prescription
Pharmaceuticals

At ROVI, we have a diversified portfolio comprising around thirty of our own and licensed products.
Our portfolio has a defensive profile, since it has been practically unaffected by reference pricing
in Spain and no significant patents will expire until 2019.

Absorcol

Absorcol®

Active Substance
Ezetimibe

Therapeutic Area
Cardiovascular

License
License from MSD

Ameride

Ameride®

Active Substance
Amiloride hydrochloride and hydrochlorothiazide

Therapeutic Area
Cardiovascular

License
ROVI propietary product

Bertanel

Bertanel®

Active Substance
Methotrexate

Therapeutic Area
Osteoarticular

License
License from Ebewe Pharma Gmbh Nfg. KG

Bluxam

BLUXAM

Active Substance
Hexacetonido de triamcinolona.

Therapeutic Area
Osteoarticular

License
License from Riemser Pharma Gmbh

Calcium and vitamine D3 ROVI

CALCIUM AND VITAMINE
D3 ROVI®

Active Substance
Calcium carbonate and cholecalciferol concentrate.

Therapeutic Area
Osteoarticular

License
ROVI propietary product

Cordiplast

CORDIPLAST®

Active Substance
Nitroglicerina

Therapeutic Area
Cardiovascular

License
License from Merus Labs Luxco II S.à.R.L.

Estraderm

ESTRADERM®

Active Substance
Estradiol. Patches

Therapeutic Area
Gynaecology

License
Merus Labs Luxco II S.à.R.L

Exxiv

EXXIV®

Active Substance
Etoricoxib

Therapeutic Area
Osteoarticular and pain release

License
License from MSD

Glufan

GLUFAN®

Active Substance
Glucosamine hydrochloride

Therapeutic Area
Osteoarticular

License
ROVI propietary product

Hibor

Hibor®

Active Substance
Sodium bemiparin

Therapeutic Area
Thrombosis

License
ROVI propietary product

Hirobriz

Hirobriz®
Breezhaler®

Active Substance
Indacaterol maleate

Therapeutic Area
Pneumology

License
License from Novartis Europharm Limited

Neparvis

NEPARVIS®

Active Substance
Sacubitril/valsartan

Therapeutic Area
Cardiovascular

License
License from Novartis Europharm Limited

Medicebran

Medicebran®

Active Substance
Methylphenidate hydrochloride with inmediate release

Therapeutic Area
Central nervous system

License
License from MEDICE

Medikinet

Medikinet®

Active Substance
Methyilphenidate hydrochloride with modified release

Therapeutic Area
Central nervous system

License
License from MEDICE

Mysimba

Mysimba®

Active Substance
Naltrexone hydrochloride and bupropion hydrochloride. Prolonged release.

Therapeutic Area
Endocrinology

License
License from OREXIGEN

Orvatez

Orvatez®

Active Substance
Ezetimibe and Atorvastatin

Therapeutic Area
Cardiovascular

License
License from MSD

Prinivil

Prinivil®

Active Substance
Lisinopril

Therapeutic Area
Cardiovascular

License
ROVI propietary product

Rhodogil

Rhodogil®

Active Substance
Spiramycin and Metronidazole

Therapeutic Area
Antibacterial

License
ROVI propietary product

Salagen

SALAGEN®

Active Substance
Pilocarpine hydrochloride

Therapeutic Area
Oncology

License
Merus Labs Luxco II S.à.R.L

Sintrom

SINTROM®

Active Substance
Acenocoumarol

Therapeutic Area
Cardiovascular

License
Merus Labs Luxco II S.à.R.L

Thymanax

Thymanax®

Active Substance
Agomelatine

Therapeutic Area
Central nervous system

License
License from SERVIER

Tryptizol

Tryptizol®

Active Substance
Amitriptyline hydrochloride

Therapeutic Area
Central nervous system

License
ROVI propietary product

Ulunar Breezhaler

Ulunar®
Breezhaler®

Active Substance
Indacaterol maleate and
glycopyrronium bromide

Therapeutic Area
Pneumology

License
License from Novartis Europharm Limited

Volutsa

Volutsa®

Active Substance
Solifenacin succinate and tamsulosin hydrochloride

Therapeutic Area
Urology

License
License from Astellas Pharma

Vytorin

Vytorin®

Active Substance
Ezetimibe and simvastatin

Therapeutic Area
Cardiovascular

License
License from MSD